It is our distinct pleasure to welcome you to the 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East. This year’s conference promises to be an exceptional gathering, showcasing cutting-edge research, innovative therapies, and collaborative efforts in the field of neurodegenerative disorders.
Our diverse program features esteemed speakers, thought-provoking sessions, and opportunities for meaningful dialogue among experts and practitioners. We are excited to explore the latest advancements and share insights that will drive progress in the understanding and treatment of Alzheimer’s disease and related conditions.
We extend our heartfelt gratitude to each of you for your commitment to advancing the field and for your participation in what we anticipate will be a truly inspiring event. Together, let us continue to push the boundaries of knowledge and work towards a future where effective treatments and preventive measures are within reach.
We look forward to your engagement and contributions throughout the conference.
Warm regards,
The “9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East” is proposed to be held April 18-20, 2025 in Abu Dhabi, United Arab Emirates (UAE). The meeting will convene clinicians including neurologists, psychiatrists, and geriatricians, nurses, public health workers, researchers, social workers, students, caregivers, and community advocates from the Middle East and North Africa (termed the MENA region), USA, Europe and other countries with an interest in epidemiology, clinical/research, medicine, basic science, and healthcare advocacy related to Alzheimer’s disease and related disorders (ADRD) in the region. Specifically, an emphasis on region specific healthcare delivery will be addressed.
Dr. Marwan Sabbagh, Vice Chair for Research and Professor in the Department of Neurology at the Barrow Neurological Institute, Professor Abdu Adem, Assistant Dean for Research, at Khalifa University, UAE, Hanan Sheikh Ibrahim MD, geriatrician from the Cleveland Clinic Abu Dhabi will be lead organizers. Dr. Robert Friedland, Professor of Neurology at University of Louisville, will also serve on the organizing committee. Dr. Sabbagh is the Principal Investigator of this application. He served as assistant organizer to Dr. Friedland, the original organizer, for three installments, co-organized the 5th, 6th and 7th installments, organized the 8th conference, and is familiar with the logistical and academic needs of these conferences. Professors Sabbagh, Adem and Ibrahim are from MENA ancestry and have a deep understanding of ME cultures.
Advance Knowledge: Present and discuss the latest research findings, scientific advancements, and clinical insights related to Alzheimer’s disease and related disorders.
Engage Stakeholders: Involve a diverse range of stakeholders, including policymakers, healthcare providers, and patient advocates, to discuss and address public health strategies and policy issues related to dementia care.
Foster Collaboration: Facilitate networking and collaboration among researchers, clinicians, and industry professionals to promote joint research efforts and the sharing of best practices.
Educate and Train: Offer educational sessions and workshops to enhance the skills and knowledge of medical professionals, researchers, and students in the field of Alzheimer’s disease and related disorders.
Explore Innovations: Showcase emerging technologies, innovative treatments, and novel approaches in the diagnosis, treatment, and management of Alzheimer’s and related conditions.
Raise Awareness: Increase public and professional awareness about Alzheimer’s disease and related disorders, their impact, and the importance of ongoing research and treatment development.
Enhance Clinical Practice: Provide healthcare professionals with up-to-date information and practical strategies for improving patient care and clinical outcomes.
Encourage Patient-Centric Approaches: Focus on the needs and perspectives of patients and their families to ensure that research and clinical practices are aligned with improving quality of life and patient outcomes.
Promote Regional Research: Highlight and support research initiatives and clinical practices specific to the Middle East, addressing regional challenges and opportunities in the field.
Foster Innovation and Investment: Encourage investment in Alzheimer’s research and development by showcasing successful case studies, innovations, and opportunities for collaboration with industry partners.
Advance Knowledge: Present and discuss the latest research findings, scientific advancements, and clinical insights related to Alzheimer’s disease and related disorders.
Foster Collaboration: Facilitate networking and collaboration among researchers, clinicians, and industry professionals to promote joint research efforts and the sharing of best practices.
Explore Innovations: Showcase emerging technologies, innovative treatments, and novel approaches in the diagnosis, treatment, and management of Alzheimer’s and related conditions.
Enhance Clinical Practice: Provide healthcare professionals with up-to-date information and practical strategies for improving patient care and clinical outcomes.
Promote Regional Research: Highlight and support research initiatives and clinical practices specific to the Middle East, addressing regional challenges and opportunities in the field.
Engage Stakeholders: Involve a diverse range of stakeholders, including policymakers, healthcare providers, and patient advocates, to discuss and address public health strategies and policy issues related to dementia care.
Educate and Train: Offer educational sessions and workshops to enhance the skills and knowledge of medical professionals, researchers, and students in the field of Alzheimer’s disease and related disorders.
Raise Awareness: Increase public and professional awareness about Alzheimer’s disease and related disorders, their impact, and the importance of ongoing research and treatment development.
Encourage Patient-Centric Approaches: Focus on the needs and perspectives of patients and their families to ensure that research and clinical practices are aligned with improving quality of life and patient outcomes.
Foster Innovation and Investment: Encourage investment in Alzheimer’s research and development by showcasing successful case studies, innovations, and opportunities for collaboration with industry partners.
